These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

233 related articles for article (PubMed ID: 33396786)

  • 1. Using X-ray Diffraction Techniques for Biomimetic Drug Development, Formulation, and Polymorphic Characterization.
    Rodríguez I; Gautam R; Tinoco AD
    Biomimetics (Basel); 2020 Dec; 6(1):. PubMed ID: 33396786
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comparison of Differential Scanning Calorimetry, Powder X-ray Diffraction, and Solid-state Nuclear Magnetic Resonance Spectroscopy for Measuring Crystallinity in Amorphous Solid Dispersions - Application to Drug-in-polymer Solubility.
    Jarrells TW; Munson EJ
    J Pharm Sci; 2022 Oct; 111(10):2765-2778. PubMed ID: 35421430
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Characterization of Amorphous Solid Dispersions and Identification of Low Levels of Crystallinity by Transmission Electron Microscopy.
    S'ari M; Blade H; Cosgrove S; Drummond-Brydson R; Hondow N; Hughes LP; Brown A
    Mol Pharm; 2021 May; 18(5):1905-1919. PubMed ID: 33797925
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Spray drying ternary amorphous solid dispersions of ibuprofen - An investigation into critical formulation and processing parameters.
    Ziaee A; Albadarin AB; Padrela L; Faucher A; O'Reilly E; Walker G
    Eur J Pharm Biopharm; 2017 Nov; 120():43-51. PubMed ID: 28822874
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Combining crystalline and polymeric excipients in API solid dispersions - Opportunity or risk?
    Veith H; Wiechert F; Luebbert C; Sadowski G
    Eur J Pharm Biopharm; 2021 Jan; 158():323-335. PubMed ID: 33296719
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Probing Molecular Packing of Amorphous Pharmaceutical Solids Using X-ray Atomic Pair Distribution Function and Solid-State NMR.
    Chen Z; Nie H; Benmore CJ; Smith PA; Du Y; Byrn S; Templeton AC; Su Y
    Mol Pharm; 2023 Nov; 20(11):5763-5777. PubMed ID: 37800667
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Analysis of amorphous and nanocrystalline solids from their X-ray diffraction patterns.
    Bates S; Zografi G; Engers D; Morris K; Crowley K; Newman A
    Pharm Res; 2006 Oct; 23(10):2333-49. PubMed ID: 17021963
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Spray Encapsulation as a Formulation Strategy for Drug-Based Room Temperature Ionic Liquids: Exploiting Drug-Polymer Immiscibility to Enable Processing for Solid Dosage Forms.
    Stocker MW; Healy AM; Ferguson S
    Mol Pharm; 2020 Sep; 17(9):3412-3424. PubMed ID: 32852215
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Evaluation of Suitable Polymeric Matrix/Carriers during Loading of Poorly Water Soluble Drugs onto Mesoporous Silica: Physical Stability and In Vitro Supersaturation.
    Kapourani A; Katopodis K; Valkanioti V; Chatzitheodoridou M; Cholevas C; Barmpalexis P
    Polymers (Basel); 2024 Mar; 16(6):. PubMed ID: 38543408
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Solid-state characterization of amorphous and mesomorphous calcium ketoprofen.
    Atassi F; Mao C; Masadeh AS; Byrn SR
    J Pharm Sci; 2010 Sep; 99(9):3684-97. PubMed ID: 19780126
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Recent Advances in Amorphous Solid Dispersions: Preformulation, Formulation Strategies, Technological Advancements and Characterization.
    Tambe S; Jain D; Meruva SK; Rongala G; Juluri A; Nihalani G; Mamidi HK; Nukala PK; Bolla PK
    Pharmaceutics; 2022 Oct; 14(10):. PubMed ID: 36297638
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Soluplus-Mediated Diosgenin Amorphous Solid Dispersion with High Solubility and High Stability: Development, Characterization and Oral Bioavailability.
    Liu P; Zhou JY; Chang JH; Liu XG; Xue HF; Wang RX; Li ZS; Li CS; Wang J; Liu CZ
    Drug Des Devel Ther; 2020; 14():2959-2975. PubMed ID: 32801637
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Navigating the Solution to Drug Formulation Problems at Research and Development Stages by Amorphous Solid Dispersion Technology.
    Tripathi D; B H MP; Sahoo J; Kumari J
    Recent Adv Drug Deliv Formul; 2023 Dec; ():. PubMed ID: 38062659
    [TBL] [Abstract][Full Text] [Related]  

  • 14. An example of how to handle amorphous fractions in API during early pharmaceutical development: SAR114137--a successful approach.
    Petzoldt C; Bley O; Byard SJ; Andert D; Baumgartner B; Nagel N; Tappertzhofen C; Feth MP
    Eur J Pharm Biopharm; 2014 Apr; 86(3):337-50. PubMed ID: 24075979
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Stable amorphous solid dispersions of fenofibrate using hot melt extrusion technology: Effect of formulation and process parameters for a low glass transition temperature drug.
    Kallakunta VR; Sarabu S; Bandari S; Batra A; Bi V; Durig T; Repka MA
    J Drug Deliv Sci Technol; 2020 Aug; 58():. PubMed ID: 32905375
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [X-ray diffractometry in the analysis of drugs and pharmaceutical forms].
    Bettinetti GP
    Boll Chim Farm; 1989 May; 128(5):149-62. PubMed ID: 2690894
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A Comparison of Spray-Drying and Co-Precipitation for the Generation of Amorphous Solid Dispersions (ASDs) of Hydrochlorothiazide and Simvastatin.
    Myślińska M; Stocker MW; Ferguson S; Healy AM
    J Pharm Sci; 2023 Aug; 112(8):2097-2114. PubMed ID: 36805392
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Amorphous dispersions of flubendazole in hydroxypropyl methylcellulose: Formulation stability assisted by pair distribution function analysis.
    Bezzon VDN; Ferreira FF; Smith P; Benmore CJ; Byrn SR; de Araujo GLB
    Int J Pharm; 2021 May; 600():120500. PubMed ID: 33753163
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Investigation into Intermolecular Interactions and Phase Behavior of Binary and Ternary Amorphous Solid Dispersions of Ketoconazole.
    Sarpal K; Tower CW; Munson EJ
    Mol Pharm; 2020 Mar; 17(3):787-801. PubMed ID: 31860316
    [TBL] [Abstract][Full Text] [Related]  

  • 20. New Development in Understanding Drug-Polymer Interactions in Pharmaceutical Amorphous Solid Dispersions from Solid-State Nuclear Magnetic Resonance.
    Pugliese A; Tobyn M; Hawarden LE; Abraham A; Blanc F
    Mol Pharm; 2022 Nov; 19(11):3685-3699. PubMed ID: 36037249
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.